Gemcitabine/carboplatin in advanced non-small-cell lung cancer: Data from randomized phase III trials

Amy D'Orazio; Chandra P. Belani

doi:10.1016/S1525-7304(11)70544-7

Gemcitabine/carboplatin in advanced non-small-cell lung cancer: Data from randomized phase III trials

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	76-79
Number of pages	4
Journal	Clinical Lung Cancer
Volume	4
Issue number	2
DOIs	https://doi.org/10.1016/S1525-7304(11)70544-7
State	Published - Sep 2002

All Science Journal Classification (ASJC) codes

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1525-7304(11)70544-7

Cite this

@article{5a73e837b7f74c788d4efbc4955ddb4b,

title = "Gemcitabine/carboplatin in advanced non-small-cell lung cancer: Data from randomized phase III trials",

author = "Amy D'Orazio and Belani, {Chandra P.}",

year = "2002",

month = sep,

doi = "10.1016/S1525-7304(11)70544-7",

language = "English (US)",

volume = "4",

pages = "76--79",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Gemcitabine/carboplatin in advanced non-small-cell lung cancer

T2 - Data from randomized phase III trials

AU - D'Orazio, Amy

AU - Belani, Chandra P.

PY - 2002/9

Y1 - 2002/9

UR - http://www.scopus.com/inward/record.url?scp=0036749815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036749815&partnerID=8YFLogxK

U2 - 10.1016/S1525-7304(11)70544-7

DO - 10.1016/S1525-7304(11)70544-7

M3 - Article

C2 - 14653862

AN - SCOPUS:0036749815

SN - 1525-7304

VL - 4

SP - 76

EP - 79

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 2

ER -

Gemcitabine/carboplatin in advanced non-small-cell lung cancer: Data from randomized phase III trials

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this